136 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
by the Company. However, its purpose is limited to instructing the registered Shareholder (the broker or agent of the broker) how to vote on behalf … is not also an annual meeting) of Shareholders called for the purpose of electing directors (whether or not called for other purposes), not later than
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
9 Aug 23
Statement of Executive Compensation
7:41pm
the Company’s 2014 Stock Option Plan which was originally adopted by the directors of the Company on April 15, 2014. The purpose of adopting the Plan … at www.sedar.com. Any definitions or capitalized terms used or referenced below have the same meaning attributed to them in the Plan.
The purpose of the Plan
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
of the extension of the Warrants and Granted Options.
the purpose and business reasons for the transaction:
Not applicable.
the anticipated effect
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
of Peter Lewis, David Hall and Peter Lowry. The purpose of the nominating, compensation and corporate governance committee is to identify individuals … Hall, Peter Lowry and Andrew Schutte. The purpose of the operations committee is to advise management of our company on all operational aspects of our
6-K
EX-99.1
rns1s60w
7 Jul 22
Statement of Executive Compensation
1:43pm
6-K
EX-99.1
ebw4pyiddedykz
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.5
zunkcedi
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
m8l 2kb12cunffwks4
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.1
bdcspobsw hd8ftq7
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
80sj8ex xh0hy
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.3
ou0qn593na7oy crbqj7
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
ewlzrvrc4up
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
hk63xm
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.6
w5mosi3f2a03j
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.8
ih4w1h3d242
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
7o2cwd29ouh998400
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am